Literature DB >> 10567912

Transient reexpression of an embryonic autonomous growth phenotype by adult carotid artery smooth muscle cells after vascular injury.

M C Weiser-Evans1, B E Quinn, M R Burkard, K R Stenmark.   

Abstract

High rates of vascular smooth muscle cell (SMC) replication are observed, at least transiently, after injury to the arterial wall and contribute to the formation of a neointima. Neutralizing antibodies designed to inhibit growth of SMC have only been variably successful in inhibiting neointima formation, raising the possibility that neointimal cell proliferation involves unique growth mechanisms. This study examined the possibility that SMC isolated from injured rat carotid arteries would express an autonomous, mitogen-independent growth phenotype similar to that utilized by embryonic vascular SMC during periods of rapid growth. We found that primary cultures of SMC isolated 7 and 14 days after injury, times at which high in vivo replication rates were observed, demonstrated high intrinsic DNA synthetic rates compared to SMC isolated from uninjured arteries or at 2, 4, 21, and 28 days after injury where in vivo replication rates were far less. Subcultured SMC isolated from 7-day injured vessels (Neo7 SMC) exhibited a stable, autonomous growth phenotype, did not secrete detectable mitogenic activity, and had decreased alpha-actin and myosin expression compared to mitogen-dependent SMC. Heterokaryons constructed between autonomous Neo7 SMC and mitogen-dependent SMC exhibited a mitogen-dependent growth phenotype suggesting that nonautonomous SMC produce factors that actively inhibit autonomous growth. In contrast, heterokaryons constructed between Neo7 SMC and autonomous embryonic SMC retained an autonomous growth phenotype. We examined the expression of known tumor suppressors to determine if any of these factors played a role in inhibiting SMC autonomous growth. p27, p53, pRb, and PTEN were abundantly expressed by Neo7 SMC and e17 SMC under both basal and serum stimulated conditions. The data suggest that the mechanisms driving SMC replication during neointimal formation are self-driven and self-regulated, and that at specific times after injury, SMC escape normal growth suppressive mechanisms through the loss of intracellular growth suppressor activity. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10567912     DOI: 10.1002/(SICI)1097-4652(200001)182:1<12::AID-JCP2>3.0.CO;2-G

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

Review 1.  Unique aspects of the developing lung circulation: structural development and regulation of vasomotor tone.

Authors:  Yuangsheng Gao; David N Cornfield; Kurt R Stenmark; Bernard Thébaud; Steven H Abman; J Usha Raj
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

2.  Parameter sensitivity study of a constrained mixture model of arterial growth and remodeling.

Authors:  A Valentín; J D Humphrey
Journal:  J Biomech Eng       Date:  2009-10       Impact factor: 2.097

3.  Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall.

Authors:  Maria G Frid; Min Li; Meena Gnanasekharan; Danielle L Burke; Miguel Fragoso; Derek Strassheim; Joanna L Sylman; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-09-18       Impact factor: 5.464

4.  Perlecan up-regulation of FRNK suppresses smooth muscle cell proliferation via inhibition of FAK signaling.

Authors:  Heather A Walker; John M Whitelock; Pamela J Garl; Raphael A Nemenoff; Kurt R Stenmark; Mary C M Weiser-Evans
Journal:  Mol Biol Cell       Date:  2003-01-26       Impact factor: 4.138

5.  Nuclear PTEN functions as an essential regulator of SRF-dependent transcription to control smooth muscle differentiation.

Authors:  Henrick Horita; Christina L Wysoczynski; Lori A Walker; Karen S Moulton; Marcella Li; Allison Ostriker; Rebecca Tucker; Timothy A McKinsey; Mair E A Churchill; Raphael A Nemenoff; Mary C M Weiser-Evans
Journal:  Nat Commun       Date:  2016-03-04       Impact factor: 14.919

6.  miR-214-3p-Sufu-GLI1 is a novel regulatory axis controlling inflammatory smooth muscle cell differentiation from stem cells and neointimal hyperplasia.

Authors:  Shiping He; Feng Yang; Mei Yang; Weiwei An; Eithne Margaret Maguire; Qishan Chen; Rui Xiao; Wei Wu; Li Zhang; Wen Wang; Qingzhong Xiao
Journal:  Stem Cell Res Ther       Date:  2020-11-03       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.